Promisingly, in numerous earlier small pilot clinical trials, magnesium sulfate showed a trend towards improving clinical outcomes in patients with aSAH [ 123 – 130 ].
← all excerpts
Current controversies in the prediction, diagnosis, and management of cerebral vasospasm: where do we stand?
1
—
—